Design and evaluation of plasmonic/magnetic Au-MFe2O4 (M-Fe/Co/Mn) core-shell nanoparticles functionalized with doxorubicin for cancer therapeutics /

Saved in:
Bibliographic Details
Author / Creator:Manisekaran, Ravichandran.
Imprint:Cham : Springer, ©2018.
Description:1 online resource (199 pages)
Language:English
Series:Springer theses
Springer theses.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11542230
Hidden Bibliographic Details
ISBN:9783319676098
3319676091
9783319676081
3319676083
Digital file characteristics:text file PDF
Notes:"Doctoral thesis accepted by Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Mexico City."
""2.1.3.4.2 Catalytic Applications""
Includes bibliographical references.
Print version record.
Summary:This thesis documents the development of a multifunctional nanoparticle system to enhance the chemotherapeutic efficiency of anti-cancer drugs, and contributes to research that helps decrease the side-effects in cancer patients while simultaneously increasing their survival rates. The work begins with an introduction to nanomedicine and cancer therapy, and contains a literature review on magnetic, gold, and core-shell nanoparticles. It also covers synthesis techniques, properties, various surface modifications, and the importance of magnetic and gold nanoparticles. The author dedicates a chapter to characterization techniques, experimental setup, and cell cultivation techniques for in-vitro studies. Further chapters describe the background, characterizations, and applications of multifunctional magnetite coated gold core-shell nanoparticles, and the doping of cobalt to magnetite and manganese to magnetite nanoparticles. The important highlight of this research was the control of the size, shape, composition, and surface chemistry of nanoparticles.
Other form:Print version: Manisekaran, Ravichandran. Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics. Cham : Springer International Publishing, ©2017 9783319676081
Standard no.:10.1007/978-3-319-67609-8